Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Castelli

Showing results (341-350 of 425) with videos related to

Pageof 43
Sort By:
Lancet (London, England)|January 10, 2018
Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studiesJosep M Llibre, Chien-Ching Hung, Cynthia Brinson, et al.
Open Forum Infectious Diseases|November 5, 2025
"ProTeggiMI": Adherence to HIV Vertical Transmission Prevention Pathway in Remote Communities in MozambiqueCarlo Cerini, Paola Magro, Aldorada da Gloria Julio Andrè, et al.
Emerging Infectious Diseases|June 15, 2013
Travel-associated illness trends and clusters, 2000-2010Karin Leder, Joseph Torresi, John S Brownstein, et al.
Infectious Diseases (London, England)|September 14, 2016
Trigger-oriented HIV testing at Internal Medicine hospital Departments in Northern Italy: an observational study (Fo.C.S. Study)Carlo Cerini, Salvatore Casari, Francesco Donato, et al.
BMJ Public Health|June 25, 2026
Clinical presentation and effectiveness of antiretroviral therapy in newly diagnosed people living with HIV before, during and after the COVID-19 pandemicAndrea Carbone, Francesca Lombardi, Giorgio Tiecco, et al.
The Journal of Infectious Diseases|July 11, 2003
Comparison between rules-based human immunodeficiency virus type 1 genotype interpretations and real or virtual phenotype: concordance analysis and correlation with clinical outcome in heavily treated patientsCarlo Torti, Eugenia Quiros-Roldan, Wilco Keulen, et al.
BMC Infectious Diseases|November 19, 2010
Travel and migration associated infectious diseases morbidity in Europe, 2008Vanessa Field, Philippe Gautret, Patricia Schlagenhauf, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 20, 2020
Valacyclovir for cytomegalovirus infection in pregnancy: additional evidences, additional questionsLorenzo Zammarchi, Tiziana Lazzarotto, Massimo Andreoni, et al.
International Journal of Environmental Research and Public Health|September 19, 2018
The Effectiveness and Cost-Effectiveness of Hepatitis C Screening for Migrants in the EU/EEA: A Systematic ReviewChristina Greenaway, Iuliia Makarenko, Claire Nour Abou Chakra, et al.
Plos One|October 24, 2017
Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A.: A modelling studyMikaela Smit, Rachel Cassidy, Alessandro Cozzi-Lepri, et al.
Pageof 43

Showing results (341-350 of 425) with videos related to

Sort By:
Pageof 43
Lancet (London, England)|January 10, 2018
Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studiesJosep M Llibre, Chien-Ching Hung, Cynthia Brinson, et al.
Open Forum Infectious Diseases|November 5, 2025
"ProTeggiMI": Adherence to HIV Vertical Transmission Prevention Pathway in Remote Communities in MozambiqueCarlo Cerini, Paola Magro, Aldorada da Gloria Julio Andrè, et al.
Emerging Infectious Diseases|June 15, 2013
Travel-associated illness trends and clusters, 2000-2010Karin Leder, Joseph Torresi, John S Brownstein, et al.
Infectious Diseases (London, England)|September 14, 2016
Trigger-oriented HIV testing at Internal Medicine hospital Departments in Northern Italy: an observational study (Fo.C.S. Study)Carlo Cerini, Salvatore Casari, Francesco Donato, et al.
BMJ Public Health|June 25, 2026
Clinical presentation and effectiveness of antiretroviral therapy in newly diagnosed people living with HIV before, during and after the COVID-19 pandemicAndrea Carbone, Francesca Lombardi, Giorgio Tiecco, et al.
The Journal of Infectious Diseases|July 11, 2003
Comparison between rules-based human immunodeficiency virus type 1 genotype interpretations and real or virtual phenotype: concordance analysis and correlation with clinical outcome in heavily treated patientsCarlo Torti, Eugenia Quiros-Roldan, Wilco Keulen, et al.
BMC Infectious Diseases|November 19, 2010
Travel and migration associated infectious diseases morbidity in Europe, 2008Vanessa Field, Philippe Gautret, Patricia Schlagenhauf, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 20, 2020
Valacyclovir for cytomegalovirus infection in pregnancy: additional evidences, additional questionsLorenzo Zammarchi, Tiziana Lazzarotto, Massimo Andreoni, et al.
International Journal of Environmental Research and Public Health|September 19, 2018
The Effectiveness and Cost-Effectiveness of Hepatitis C Screening for Migrants in the EU/EEA: A Systematic ReviewChristina Greenaway, Iuliia Makarenko, Claire Nour Abou Chakra, et al.
Plos One|October 24, 2017
Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A.: A modelling studyMikaela Smit, Rachel Cassidy, Alessandro Cozzi-Lepri, et al.
Pageof 43